Snap says its $400M Perplexity AI search deal ended amicably

Snap disclosed in its Q1 2026 investor materials that it “amicably ended” its relationship with Perplexity, removing an expected contribution from the partnership.

The original deal was reported as a $400 million cash-and-equity arrangement to bring Perplexity-powered AI search into Snapchat. Its end matters because distribution has been one of the biggest open questions for AI search companies: do they win through direct apps, browsers, operating systems, or partnerships inside large consumer platforms?

Why this matters

Perplexity has been pushing beyond a standalone answer engine into browsers, agentic research, and premium data integrations. A Snapchat integration would have given it a large consumer surface with a younger audience and habitual daily use.

Losing or walking away from that path does not weaken Perplexity’s core product, but it does make the distribution story more focused on Comet, the Perplexity app, enterprise search, and Computer-style workflows.

For Snap, the end of the deal narrows one AI-search experiment while the company continues to face pressure to prove that AI features can improve engagement and monetization without adding cost complexity.

Buyer take

For Perplexity buyers, this is not a product downgrade. It is a strategy signal. Perplexity seems more likely to win through high-intent research surfaces than through casual social search inside Snapchat.

For founders building consumer AI search, the lesson is blunt: distribution partnerships are attractive, but they are fragile. The partner must see durable engagement, revenue lift, and brand fit quickly enough to justify integration work.

For advertisers and commerce teams, watch whether social platforms build their own AI answer layers instead of outsourcing them to search startups.

What is still unclear

Snap has not published a detailed postmortem explaining why the Perplexity deal ended. Without that, it is not possible to say whether the issue was usage, economics, timing, product fit, privacy, or broader strategic reprioritization.